{"gene":"TAFA4","run_date":"2026-06-10T10:51:54","timeline":{"discoveries":[{"year":2013,"finding":"TAFA4 is a specific marker of C-low-threshold mechanoreceptors (C-LTMRs). TAFA4-null mice exhibit enhanced mechanical and chemical hypersensitivity following inflammation and nerve injury, with increased excitability of spinal cord lamina IIi neurons. Intrathecal or bath application of recombinant TAFA4 protein reversed this increased excitability, and intrathecal administration strongly reversed carrageenan-induced mechanical hypersensitivity in wild-type mice, establishing an analgesic role for C-LTMR-derived TAFA4 in modulating neuronal excitability and somatic sensation thresholds.","method":"Genetic labeling, electrophysiological recordings, TAFA4-null mouse model (loss-of-function), intrathecal and bath application of recombinant TAFA4 protein","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO mouse with defined cellular phenotype, rescue with recombinant protein, electrophysiology, replicated across multiple pain models","pmids":["24139797"],"is_preprint":false},{"year":2014,"finding":"FAM19A4 (TAFA4) is a ligand of formyl peptide receptor 1 (FPR1). The mature protein is composed of 95 amino acids. FAM19A4 shows chemotactic activity on macrophages, enhances macrophage phagocytosis of zymosan (with increased Akt phosphorylation), and increases reactive oxygen species (ROS) release. These activities were demonstrated by receptor internalization assays, radioligand binding assays, and receptor blockage experiments.","method":"Receptor internalization assay, radioligand binding assay, receptor blockage, in vitro chemotaxis assay, in vivo phagocytosis assay, western blot for Akt phosphorylation","journal":"Cellular & molecular immunology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (radioligand binding, receptor internalization, blockade, functional assays) in single lab establishing receptor-ligand relationship","pmids":["25109685"],"is_preprint":false},{"year":2021,"finding":"Sensory neuron-derived TAFA4, produced specifically by C-low threshold mechanoreceptors (a subset of GINIP+ neurons), promotes the tissue-repair function of dermal macrophages. In vivo, TAFA4-deficient mice showed defective tissue regeneration and dermal fibrosis after UV-induced skin damage. TAFA4 modulates the inflammatory profile of macrophages directly in vitro. A TAFA4-IL-10 axis was identified whereby TAFA4 promotes IL-10 production by dermal macrophages and ensures survival and maintenance of IL-10+TIM4+ dermal macrophages, reducing inflammation and promoting tissue regeneration.","method":"Conditional sensory neuron ablation, Tafa4-deficient mouse model, in vitro macrophage stimulation, in vivo UV-skin damage model, flow cytometry, histology","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with defined cellular phenotype, in vitro mechanistic validation, multiple orthogonal methods, published in high-impact journal","pmids":["34012116"],"is_preprint":false},{"year":2021,"finding":"TAFA4 reverses inflammatory, postoperative, and spared nerve injury (SNI)-induced mechanical hypersensitivity through functional low-density lipoprotein receptor-related proteins (LRPs), as their inhibition by RAP (receptor-associated protein) dose-dependently abolished TAFA4's antihypersensitive actions. SNI selectively decreases A-type K+ current (IA) in spinal lamina II outer excitatory interneurons and alters Ih in lamina II inner inhibitory interneurons; these ion current alterations were rescued by TAFA4 in an LRP-dependent manner.","method":"In vivo mechanical hypersensitivity assays, pharmacological inhibition (RAP), electrophysiological recordings of spinal interneuron ion currents, multiple pain models (inflammatory, postoperative, SNI)","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — electrophysiology with pharmacological rescue, multiple orthogonal pain models, LRP receptor requirement confirmed by dose-dependent blockade","pmids":["34706225"],"is_preprint":false},{"year":2022,"finding":"TAFA4 activates dendritic cells (DCs) in airway tissues, inducing IL-10 expression via the FPR1-MyD88-AKT signaling pathway. TAFA4 also promotes activities of c-Maf inducing protein in DCs. Co-administration of TAFA4 with allergen immunotherapy induced antigen-specific Tr1 regulatory T cells and attenuated allergic rhinitis response in mice.","method":"Mouse allergic rhinitis model, DC stimulation in vitro, signaling pathway inhibitor assays (FPR1-MyD88-AKT), flow cytometry for Tr1 cells","journal":"NPJ vaccines","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — defined signaling pathway (FPR1-MyD88-AKT) with functional readout, single lab, pathway assignment based on inhibitor assays without full mutagenesis","pmids":["36316414"],"is_preprint":false},{"year":2023,"finding":"TAFA4 modulates FcεRI expression in mast cells through the TAFA4-PTEN-PU.1 signaling axis, which restricts transcription of Fcer1g (FcεRI γ gene). TAFA4 suppressed antigen-related mast cell activation and attenuated experimental allergic rhinitis. Negative correlation between TAFA4 and tryptase levels in nasal secretions from allergic rhinitis patients was observed.","method":"ELISA (nasal secretions from patients), mouse allergic rhinitis model, in vitro mast cell stimulation, transcriptional analysis of Fcer1g, PTEN-PU.1 pathway interrogation","journal":"Clinical and experimental immunology","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — signaling pathway identified (TAFA4-PTEN-PU.1-FcεRI) but mechanistic details (e.g., direct binding, mutagenesis) not clearly established from abstract alone, single lab","pmids":["36368013"],"is_preprint":false},{"year":2025,"finding":"TAFA4 overexpression in dorsal root ganglia (DRG) ameliorates neuropathic pain by promoting macrophage M2 polarization in the DRGs. Mechanistically, TAFA4 modulates macrophage function in a lipoprotein receptor-related protein 1 (LRP1)-dependent manner. TAFA4 overexpression (via scAAV) increased IL-10 concentrations in DRG and inhibited pro-inflammatory mediators after chronic constriction injury.","method":"Chronic constriction injury (CCI) rat model, scAAV-mediated TAFA4 overexpression, flow cytometry, western blot, immunofluorescence, ELISA","journal":"Neurochemistry international","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — defined LRP1-dependent mechanism with in vivo AAV rescue experiment, single lab, mechanistic detail limited to abstract description","pmids":["40381955"],"is_preprint":false},{"year":2026,"finding":"FAM19A4 enhances neutrophil reactive oxygen species (ROS) production specifically through p38 MAPK signaling activation. FAM19A4 deficiency (Fam19a4 knockout mice) in a cecal ligation and puncture (CLP) sepsis model improved survival and reduced multiorgan injury, reduced neutrophil and macrophage counts in lungs and liver, and decreased neutrophil extracellular trap (NET) formation. In vitro, FAM19A4 enhanced neutrophil phagocytosis and ROS generation but did not affect LPS-induced chemotaxis.","method":"Fam19a4 knockout mouse CLP sepsis model, bulk RNA sequencing, western blot, p38 MAPK inhibitor (SB203580) treatment, bioluminescence ROS tracking, flow cytometry, in vitro neutrophil assays","journal":"Acta biochimica et biophysica Sinica","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse with defined phenotype, p38 MAPK pathway confirmed by inhibitor and RNA-seq, multiple orthogonal methods, single lab","pmids":["41517951"],"is_preprint":false},{"year":2026,"finding":"TAFA4 acts as a neuron-derived mediator in intervertebral disc degeneration (IVDD). GINIP+ sensory neurons secrete TAFA4 in degenerative discs. In vitro, GINIP+ neurons promoted macrophage M2 polarization and IL-10 production while suppressing TNF-α and IL-1β; these effects were reversed by TAFA4 knockdown. TAFA4 attenuated ROS-dependent NLRP3 inflammasome activation in macrophages.","method":"In vivo IVDD model with lentiviral TAFA4 knockdown, in vitro neuron-macrophage co-culture, flow cytometry, immunofluorescence, ELISA, western blot","journal":"Neurospine","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — defined pathway (TAFA4→macrophage M2/IL-10→NLRP3 suppression) with multiple in vitro and in vivo methods, single lab","pmids":["41666872"],"is_preprint":false},{"year":2026,"finding":"During herpes simplex virus type 1 infection, sensory neurons produce TAFA4. In infected dorsal root ganglia (DRGs), a TAFA4-IL-10 pathway promotes the resolution of inflammation after viral clearance, functioning independently from substance P actions in skin. This neuroimmune regulatory pathway reduces detrimental impact of infection on host fitness without directly altering pathogen elimination.","method":"HSV-1 mouse infection model, tissue-specific analysis of DRG vs. skin, genetic and pharmacological dissection of SP and TAFA4 pathways","journal":"Immunity","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — defined TAFA4-IL-10 axis in DRG with in vivo viral infection model, tissue-specific pathway established, single lab","pmids":["41747735"],"is_preprint":false},{"year":2024,"finding":"In a Shank3 mouse model of autism, C-fiber low-threshold mechanoreceptors (C-LTMRs) are hyporesponsive and TAFA4 is transcriptomically downregulated. TAFA4 injection reduced spontaneous scratching response to skin deformation but failed to restore itch sensitivity, suggesting TAFA4 modulates one component of mechanical itch but not the full alloknesis pathway.","method":"Ex vivo electrophysiology of C-LTMRs, transcriptomic analysis, TAFA4 pharmacological injection, Shank3 ΔC/ΔC mouse model","journal":"bioRxiv","confidence":"Low","confidence_rationale":"Tier 3 / Weak — preprint, partial mechanistic follow-up, negative result for itch restoration, single lab","pmids":["bio_10.1101_2024.12.29.630575"],"is_preprint":true}],"current_model":"TAFA4 is a secreted neuropeptide/neurokine produced primarily by C-low-threshold mechanoreceptors (C-LTMRs) that acts as a ligand for formyl peptide receptor 1 (FPR1) and lipoprotein receptor-related proteins (LRPs) to exert analgesic effects by modulating spinal cord interneuron excitability (via A-type K+ currents) and to drive anti-inflammatory, pro-repair macrophage responses (via TAFA4-IL-10 axis and LRP1-dependent M2 polarization), while also signaling through FPR1-MyD88-AKT in dendritic cells and through a PTEN-PU.1 axis in mast cells to suppress allergic responses, and promoting neutrophil ROS production through p38 MAPK during sepsis."},"narrative":{"mechanistic_narrative":"TAFA4 (FAM19A4) is a secreted neurokine produced by C-low-threshold mechanoreceptors (C-LTMRs), a subset of GINIP+ sensory neurons, that links somatosensory neurons to neuronal excitability control and innate immune regulation [PMID:24139797, PMID:34012116]. As a marker of C-LTMRs, neuron-derived TAFA4 exerts an analgesic role: TAFA4-null mice show enhanced mechanical and chemical hypersensitivity with hyperexcitable spinal lamina II interneurons, and recombinant TAFA4 reverses this excitability and carrageenan-induced hypersensitivity [PMID:24139797]. This antihypersensitive action operates through low-density lipoprotein receptor-related proteins (LRPs), with TAFA4 normalizing injury-induced changes in A-type K+ current and Ih in spinal interneurons in an LRP-dependent manner [PMID:34706225]. Independently, TAFA4 functions as a ligand for formyl peptide receptor 1 (FPR1), driving macrophage chemotaxis, phagocytosis, Akt phosphorylation, and ROS release [PMID:25109685]. Across tissues TAFA4 reprograms innate immune cells toward anti-inflammatory, pro-repair states, promoting macrophage M2 polarization and IL-10 production—via an LRP1-dependent route in dorsal root ganglia—to limit fibrosis, neuropathic pain, NLRP3 inflammasome activation, and post-infection inflammation [PMID:34012116, PMID:40381955, PMID:41666872, PMID:41747735]. In adaptive and allergic immunity, TAFA4 signals through FPR1-MyD88-AKT in dendritic cells to induce Tr1 cells and through a PTEN-PU.1 axis in mast cells to restrict FcεRI expression, attenuating allergic rhinitis [PMID:36316414, PMID:36368013]. In contrast, during sepsis TAFA4 enhances neutrophil ROS and NET formation through p38 MAPK, where its deficiency improves survival [PMID:41517951].","teleology":[{"year":2013,"claim":"Established that a C-LTMR-specific secreted factor controls somatosensory thresholds, defining TAFA4 as an endogenous analgesic neuromodulator rather than a passive neuronal marker.","evidence":"Genetic labeling, TAFA4-null mice, spinal electrophysiology, and rescue by intrathecal/bath recombinant TAFA4 across multiple pain models","pmids":["24139797"],"confidence":"High","gaps":["Receptor mediating the neuronal excitability effect not identified in this study","Molecular target of the excitability change (ion channel) not resolved"]},{"year":2014,"claim":"Identified a receptor for TAFA4, showing it acts as an FPR1 ligand to control macrophage chemotaxis and effector functions, opening an immune dimension to a neuronal factor.","evidence":"Radioligand binding, receptor internalization and blockade assays, in vitro chemotaxis, in vivo phagocytosis, and Akt phosphorylation western blot","pmids":["25109685"],"confidence":"High","gaps":["Whether FPR1 mediates the in vivo analgesic effect not tested","No structural basis for TAFA4-FPR1 binding"]},{"year":2021,"claim":"Connected neuron-derived TAFA4 to tissue repair via a defined TAFA4-IL-10 macrophage axis, establishing a neuroimmune circuit controlling dermal macrophage survival and inflammatory tone.","evidence":"Conditional sensory neuron ablation, Tafa4-deficient mice, UV-skin damage model, in vitro macrophage stimulation, flow cytometry, histology","pmids":["34012116"],"confidence":"High","gaps":["Receptor on dermal macrophages not defined in this study","Direct vs indirect induction of IL-10 not fully separated"]},{"year":2021,"claim":"Resolved the receptor requirement for TAFA4's analgesic action, showing LRPs mediate normalization of specific spinal interneuron ion currents.","evidence":"Multiple pain models, RAP pharmacological blockade, and electrophysiological recording of A-type K+ current and Ih in spinal interneurons","pmids":["34706225"],"confidence":"High","gaps":["Specific LRP family member not pinpointed","Downstream signaling from LRP to ion channels unresolved"]},{"year":2022,"claim":"Extended TAFA4 signaling to dendritic cells, defining an FPR1-MyD88-AKT pathway that drives regulatory T cell induction and dampens allergic responses.","evidence":"Mouse allergic rhinitis model, in vitro DC stimulation, pathway inhibitor assays, flow cytometry for Tr1 cells","pmids":["36316414"],"confidence":"Medium","gaps":["Pathway assigned by inhibitors without mutagenesis","Single lab"]},{"year":2023,"claim":"Identified a distinct mast-cell mechanism, the TAFA4-PTEN-PU.1 axis restricting Fcer1g transcription, broadening TAFA4's suppression of allergic activation.","evidence":"Patient nasal secretion ELISA, mouse allergic rhinitis model, in vitro mast cell stimulation, Fcer1g transcriptional analysis","pmids":["36368013"],"confidence":"Medium","gaps":["No direct binding or receptor identified for the mast cell effect","Mechanistic link from receptor to PTEN unestablished"]},{"year":2025,"claim":"Demonstrated that boosting TAFA4 alleviates neuropathic pain via LRP1-dependent macrophage M2 polarization, unifying analgesic and immunomodulatory functions in a gain-of-function setting.","evidence":"CCI rat model with scAAV-mediated TAFA4 overexpression, flow cytometry, western blot, immunofluorescence, ELISA","pmids":["40381955"],"confidence":"Medium","gaps":["Mechanistic detail limited","Relationship between LRP1 macrophage signaling and the earlier neuronal LRP effect not reconciled"]},{"year":2026,"claim":"Showed a context-dependent pro-inflammatory role in sepsis, where TAFA4 enhances neutrophil ROS and NET formation via p38 MAPK and its loss is protective, revealing the factor is not uniformly anti-inflammatory.","evidence":"Fam19a4 knockout CLP sepsis model, bulk RNA-seq, p38 inhibitor SB203580, ROS bioluminescence tracking, in vitro neutrophil assays","pmids":["41517951"],"confidence":"Medium","gaps":["Receptor mediating neutrophil effect not identified","Source of TAFA4 in sepsis not defined"]},{"year":2026,"claim":"Generalized the TAFA4-IL-10 anti-inflammatory axis to disc degeneration and viral infection, establishing TAFA4 as a neuron-to-macrophage signal resolving inflammation across diverse pathologies.","evidence":"IVDD model with lentiviral TAFA4 knockdown and neuron-macrophage co-culture; HSV-1 DRG infection model with genetic/pharmacological dissection of TAFA4 vs substance P","pmids":["41666872","41747735"],"confidence":"Medium","gaps":["Receptor mediating M2/IL-10 induction not resolved in these systems","NLRP3 suppression mechanism beyond ROS not defined"]},{"year":null,"claim":"How a single secreted factor selects among distinct receptors (FPR1 vs LRP/LRP1) and opposing immune outcomes (anti-inflammatory IL-10/M2 vs pro-inflammatory neutrophil ROS) in a cell- and context-specific manner remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural or biochemical basis distinguishing FPR1 vs LRP engagement","Determinants of pro- vs anti-inflammatory switching unknown","Receptor mediating spinal neuronal excitability changes not molecularly defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[1,4]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,3,5]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,1,2]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[1,2,4,5,7]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,3]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,4,6]}],"complexes":[],"partners":["FPR1","LRP1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q96LR4","full_name":"Chemokine-like protein TAFA-4","aliases":[],"length_aa":140,"mass_kda":15.7,"function":"Modulates injury-induced and chemical pain hypersensitivity (By similarity). Ligand of FPR1, can chemoattract macrophages, promote phagocytosis and increase ROS release (PubMed:25109685)","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/Q96LR4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TAFA4","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TAFA4","total_profiled":1310},"omim":[{"mim_id":"617498","title":"FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A4, CC MOTIF CHEMOKINE-LIKE; FAM19A4","url":"https://www.omim.org/entry/617498"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"adrenal gland","ntpm":14.1},{"tissue":"brain","ntpm":6.9},{"tissue":"retina","ntpm":10.3},{"tissue":"stomach 1","ntpm":4.6}],"url":"https://www.proteinatlas.org/search/TAFA4"},"hgnc":{"alias_symbol":["TAFA-4"],"prev_symbol":["FAM19A4"]},"alphafold":{"accession":"Q96LR4","domains":[{"cath_id":"-","chopping":"51-136","consensus_level":"medium","plddt":95.4872,"start":51,"end":136}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96LR4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96LR4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96LR4-F1-predicted_aligned_error_v6.png","plddt_mean":85.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TAFA4","jax_strain_url":"https://www.jax.org/strain/search?query=TAFA4"},"sequence":{"accession":"Q96LR4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96LR4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96LR4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96LR4"}},"corpus_meta":[{"pmid":"34012116","id":"PMC_34012116","title":"Sensory neuron-derived TAFA4 promotes macrophage tissue repair functions.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34012116","citation_count":157,"is_preprint":false},{"pmid":"25281488","id":"PMC_25281488","title":"Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions.","date":"2014","source":"Cancer prevention research (Philadelphia, Pa.)","url":"https://pubmed.ncbi.nlm.nih.gov/25281488","citation_count":115,"is_preprint":false},{"pmid":"24139797","id":"PMC_24139797","title":"TAFA4, a chemokine-like protein, modulates injury-induced mechanical and chemical pain hypersensitivity in mice.","date":"2013","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/24139797","citation_count":114,"is_preprint":false},{"pmid":"32997803","id":"PMC_32997803","title":"Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study.","date":"2020","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32997803","citation_count":104,"is_preprint":false},{"pmid":"26921784","id":"PMC_26921784","title":"Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women.","date":"2016","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/26921784","citation_count":90,"is_preprint":false},{"pmid":"29663363","id":"PMC_29663363","title":"Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.","date":"2018","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29663363","citation_count":84,"is_preprint":false},{"pmid":"25109685","id":"PMC_25109685","title":"FAM19A4 is a novel cytokine ligand of formyl peptide receptor 1 (FPR1) and is able to promote the migration and phagocytosis of macrophages.","date":"2014","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25109685","citation_count":71,"is_preprint":false},{"pmid":"35512257","id":"PMC_35512257","title":"Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With Absence of FAM19A4/miR124-2 DNA Methylation (CONCERVE Study).","date":"2022","source":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35512257","citation_count":66,"is_preprint":false},{"pmid":"31390052","id":"PMC_31390052","title":"FAM19A4/miR124-2 methylation in invasive cervical cancer: A retrospective cross-sectional worldwide study.","date":"2019","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31390052","citation_count":65,"is_preprint":false},{"pmid":"26317579","id":"PMC_26317579","title":"Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).","date":"2015","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26317579","citation_count":62,"is_preprint":false},{"pmid":"32222459","id":"PMC_32222459","title":"FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort.","date":"2020","source":"Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","url":"https://pubmed.ncbi.nlm.nih.gov/32222459","citation_count":47,"is_preprint":false},{"pmid":"31182225","id":"PMC_31182225","title":"Long-term CIN3+ risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysis.","date":"2019","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31182225","citation_count":43,"is_preprint":false},{"pmid":"33729551","id":"PMC_33729551","title":"Classification of high-grade cervical intraepithelial neoplasia by p16ink4a , Ki-67, HPV E4 and FAM19A4/miR124-2 methylation status demonstrates considerable heterogeneity with potential consequences for management.","date":"2021","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33729551","citation_count":39,"is_preprint":false},{"pmid":"30486875","id":"PMC_30486875","title":"The clinical significance of FAM19A4 methylation in high-risk HPV-positive cervical samples for the detection of cervical (pre)cancer in Chinese women.","date":"2018","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30486875","citation_count":33,"is_preprint":false},{"pmid":"30758084","id":"PMC_30758084","title":"Intra- and inter-laboratory agreement of the FAM19A4/mir124-2 methylation test: Results from an international study.","date":"2019","source":"Journal of clinical laboratory analysis","url":"https://pubmed.ncbi.nlm.nih.gov/30758084","citation_count":29,"is_preprint":false},{"pmid":"35712659","id":"PMC_35712659","title":"Molecular Structure, Expression and Role of TAFA4 and its Receptor FPR1 in the Spinal Cord.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/35712659","citation_count":25,"is_preprint":false},{"pmid":"34706225","id":"PMC_34706225","title":"TAFA4 relieves injury-induced mechanical hypersensitivity through LDL receptors and modulation of spinal A-type K+ current.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/34706225","citation_count":23,"is_preprint":false},{"pmid":"35686306","id":"PMC_35686306","title":"FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years.","date":"2023","source":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","url":"https://pubmed.ncbi.nlm.nih.gov/35686306","citation_count":21,"is_preprint":false},{"pmid":"32022461","id":"PMC_32022461","title":"Expression of p16 and HPV E4 on biopsy samples and methylation of FAM19A4 and miR124-2 on cervical cytology samples in the classification of cervical squamous intraepithelial lesions.","date":"2020","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32022461","citation_count":17,"is_preprint":false},{"pmid":"38668267","id":"PMC_38668267","title":"FAM19A4 and hsa-miR124-2 Double Methylation as Screening for ASC-H- and CIN1 HPV-Positive Women.","date":"2024","source":"Pathogens (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/38668267","citation_count":16,"is_preprint":false},{"pmid":"31289088","id":"PMC_31289088","title":"Role of FAM19A4/miR124-2 methylation analysis in predicting regression or non-regression of CIN2/3 lesions: a protocol of an observational longitudinal cohort study.","date":"2019","source":"BMJ open","url":"https://pubmed.ncbi.nlm.nih.gov/31289088","citation_count":14,"is_preprint":false},{"pmid":"30219239","id":"PMC_30219239","title":"Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16/18 and FAM19A4/miR124-2 methylation.","date":"2018","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30219239","citation_count":9,"is_preprint":false},{"pmid":"37964497","id":"PMC_37964497","title":"Cervix cytology samples revealed increased methylation of the human markers FAM19A4/miR124-2 up to 8 years before adenocarcinoma.","date":"2023","source":"Acta obstetricia et gynecologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/37964497","citation_count":7,"is_preprint":false},{"pmid":"25979463","id":"PMC_25979463","title":"Efficient production of FAM19A4, a novel potential cytokine, in a stable optimized CHO-S cell system.","date":"2015","source":"Protein expression and purification","url":"https://pubmed.ncbi.nlm.nih.gov/25979463","citation_count":6,"is_preprint":false},{"pmid":"36316414","id":"PMC_36316414","title":"TAFA4-IL-10 axis potentiate immunotherapy for airway allergy by induction of specific regulatory T cells.","date":"2022","source":"NPJ vaccines","url":"https://pubmed.ncbi.nlm.nih.gov/36316414","citation_count":5,"is_preprint":false},{"pmid":"38960143","id":"PMC_38960143","title":"DNA methylation at individual CpG-sites of EPB41L3, HTERT and FAM19A4 are useful for detection of cervical high-grade squamous intraepithelial lesions (HSIL) or worse: Analysis of individual CpG-sites outperforms averaging.","date":"2024","source":"Tumour virus research","url":"https://pubmed.ncbi.nlm.nih.gov/38960143","citation_count":3,"is_preprint":false},{"pmid":"36368013","id":"PMC_36368013","title":"Signals from the TAFA4-PTEN-PU.1 axis alleviate nasal allergy by modulating the expression of FcεRI in mast cells.","date":"2023","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36368013","citation_count":3,"is_preprint":false},{"pmid":"40381955","id":"PMC_40381955","title":"Overexpression of TAFA4 in the dorsal root ganglion ameliorates neuropathic pain in male rats through promoting macrophage M2-Skewing.","date":"2025","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/40381955","citation_count":2,"is_preprint":false},{"pmid":"41747735","id":"PMC_41747735","title":"Sensory neuron production of substance P and TAFA4 promotes disease tolerance during viral infection.","date":"2026","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/41747735","citation_count":1,"is_preprint":false},{"pmid":"41094556","id":"PMC_41094556","title":"FAM19A4 and miR124-2 methylation status in human papillomavirus-driven and human papillomavirus-negative oropharyngeal squamous cell carcinomas.","date":"2025","source":"Infectious agents and cancer","url":"https://pubmed.ncbi.nlm.nih.gov/41094556","citation_count":1,"is_preprint":false},{"pmid":"29167066","id":"PMC_29167066","title":"Method for quantitative detection of FAM19A4 by flow cytometry using latex beads as solid carrier.","date":"2017","source":"Journal of bioscience and bioengineering","url":"https://pubmed.ncbi.nlm.nih.gov/29167066","citation_count":1,"is_preprint":false},{"pmid":"41517951","id":"PMC_41517951","title":"FAM19A4 enhances neutrophil respiratory burst via p38 MAPK in lethal sepsis.","date":"2026","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/41517951","citation_count":0,"is_preprint":false},{"pmid":"41666872","id":"PMC_41666872","title":"TAFA4 Mitigates Intervertebral Disc Degeneration by Modulating Macrophage Polarization and Inhibiting ROS-NLRP3 Inflammasome Activation.","date":"2026","source":"Neurospine","url":"https://pubmed.ncbi.nlm.nih.gov/41666872","citation_count":0,"is_preprint":false},{"pmid":"31269601","id":"PMC_31269601","title":"[Detection and analysis of FAM19A4 promoter methylation in cervical exfoliated cells].","date":"2019","source":"Zhonghua yi xue za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/31269601","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.12.29.630575","title":"Primary sensory neuron dysfunction underlying mechanical itch hypersensitivity in a Shank3 mouse model of autism","date":"2024-12-29","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.29.630575","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":23064,"output_tokens":3422,"usd":0.060261,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":11052,"output_tokens":3408,"usd":0.07023,"stage2_stop_reason":"end_turn"},"total_usd":0.130491,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2013,\n      \"finding\": \"TAFA4 is a specific marker of C-low-threshold mechanoreceptors (C-LTMRs). TAFA4-null mice exhibit enhanced mechanical and chemical hypersensitivity following inflammation and nerve injury, with increased excitability of spinal cord lamina IIi neurons. Intrathecal or bath application of recombinant TAFA4 protein reversed this increased excitability, and intrathecal administration strongly reversed carrageenan-induced mechanical hypersensitivity in wild-type mice, establishing an analgesic role for C-LTMR-derived TAFA4 in modulating neuronal excitability and somatic sensation thresholds.\",\n      \"method\": \"Genetic labeling, electrophysiological recordings, TAFA4-null mouse model (loss-of-function), intrathecal and bath application of recombinant TAFA4 protein\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO mouse with defined cellular phenotype, rescue with recombinant protein, electrophysiology, replicated across multiple pain models\",\n      \"pmids\": [\"24139797\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"FAM19A4 (TAFA4) is a ligand of formyl peptide receptor 1 (FPR1). The mature protein is composed of 95 amino acids. FAM19A4 shows chemotactic activity on macrophages, enhances macrophage phagocytosis of zymosan (with increased Akt phosphorylation), and increases reactive oxygen species (ROS) release. These activities were demonstrated by receptor internalization assays, radioligand binding assays, and receptor blockage experiments.\",\n      \"method\": \"Receptor internalization assay, radioligand binding assay, receptor blockage, in vitro chemotaxis assay, in vivo phagocytosis assay, western blot for Akt phosphorylation\",\n      \"journal\": \"Cellular & molecular immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (radioligand binding, receptor internalization, blockade, functional assays) in single lab establishing receptor-ligand relationship\",\n      \"pmids\": [\"25109685\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Sensory neuron-derived TAFA4, produced specifically by C-low threshold mechanoreceptors (a subset of GINIP+ neurons), promotes the tissue-repair function of dermal macrophages. In vivo, TAFA4-deficient mice showed defective tissue regeneration and dermal fibrosis after UV-induced skin damage. TAFA4 modulates the inflammatory profile of macrophages directly in vitro. A TAFA4-IL-10 axis was identified whereby TAFA4 promotes IL-10 production by dermal macrophages and ensures survival and maintenance of IL-10+TIM4+ dermal macrophages, reducing inflammation and promoting tissue regeneration.\",\n      \"method\": \"Conditional sensory neuron ablation, Tafa4-deficient mouse model, in vitro macrophage stimulation, in vivo UV-skin damage model, flow cytometry, histology\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with defined cellular phenotype, in vitro mechanistic validation, multiple orthogonal methods, published in high-impact journal\",\n      \"pmids\": [\"34012116\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TAFA4 reverses inflammatory, postoperative, and spared nerve injury (SNI)-induced mechanical hypersensitivity through functional low-density lipoprotein receptor-related proteins (LRPs), as their inhibition by RAP (receptor-associated protein) dose-dependently abolished TAFA4's antihypersensitive actions. SNI selectively decreases A-type K+ current (IA) in spinal lamina II outer excitatory interneurons and alters Ih in lamina II inner inhibitory interneurons; these ion current alterations were rescued by TAFA4 in an LRP-dependent manner.\",\n      \"method\": \"In vivo mechanical hypersensitivity assays, pharmacological inhibition (RAP), electrophysiological recordings of spinal interneuron ion currents, multiple pain models (inflammatory, postoperative, SNI)\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — electrophysiology with pharmacological rescue, multiple orthogonal pain models, LRP receptor requirement confirmed by dose-dependent blockade\",\n      \"pmids\": [\"34706225\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TAFA4 activates dendritic cells (DCs) in airway tissues, inducing IL-10 expression via the FPR1-MyD88-AKT signaling pathway. TAFA4 also promotes activities of c-Maf inducing protein in DCs. Co-administration of TAFA4 with allergen immunotherapy induced antigen-specific Tr1 regulatory T cells and attenuated allergic rhinitis response in mice.\",\n      \"method\": \"Mouse allergic rhinitis model, DC stimulation in vitro, signaling pathway inhibitor assays (FPR1-MyD88-AKT), flow cytometry for Tr1 cells\",\n      \"journal\": \"NPJ vaccines\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — defined signaling pathway (FPR1-MyD88-AKT) with functional readout, single lab, pathway assignment based on inhibitor assays without full mutagenesis\",\n      \"pmids\": [\"36316414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TAFA4 modulates FcεRI expression in mast cells through the TAFA4-PTEN-PU.1 signaling axis, which restricts transcription of Fcer1g (FcεRI γ gene). TAFA4 suppressed antigen-related mast cell activation and attenuated experimental allergic rhinitis. Negative correlation between TAFA4 and tryptase levels in nasal secretions from allergic rhinitis patients was observed.\",\n      \"method\": \"ELISA (nasal secretions from patients), mouse allergic rhinitis model, in vitro mast cell stimulation, transcriptional analysis of Fcer1g, PTEN-PU.1 pathway interrogation\",\n      \"journal\": \"Clinical and experimental immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — signaling pathway identified (TAFA4-PTEN-PU.1-FcεRI) but mechanistic details (e.g., direct binding, mutagenesis) not clearly established from abstract alone, single lab\",\n      \"pmids\": [\"36368013\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TAFA4 overexpression in dorsal root ganglia (DRG) ameliorates neuropathic pain by promoting macrophage M2 polarization in the DRGs. Mechanistically, TAFA4 modulates macrophage function in a lipoprotein receptor-related protein 1 (LRP1)-dependent manner. TAFA4 overexpression (via scAAV) increased IL-10 concentrations in DRG and inhibited pro-inflammatory mediators after chronic constriction injury.\",\n      \"method\": \"Chronic constriction injury (CCI) rat model, scAAV-mediated TAFA4 overexpression, flow cytometry, western blot, immunofluorescence, ELISA\",\n      \"journal\": \"Neurochemistry international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — defined LRP1-dependent mechanism with in vivo AAV rescue experiment, single lab, mechanistic detail limited to abstract description\",\n      \"pmids\": [\"40381955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"FAM19A4 enhances neutrophil reactive oxygen species (ROS) production specifically through p38 MAPK signaling activation. FAM19A4 deficiency (Fam19a4 knockout mice) in a cecal ligation and puncture (CLP) sepsis model improved survival and reduced multiorgan injury, reduced neutrophil and macrophage counts in lungs and liver, and decreased neutrophil extracellular trap (NET) formation. In vitro, FAM19A4 enhanced neutrophil phagocytosis and ROS generation but did not affect LPS-induced chemotaxis.\",\n      \"method\": \"Fam19a4 knockout mouse CLP sepsis model, bulk RNA sequencing, western blot, p38 MAPK inhibitor (SB203580) treatment, bioluminescence ROS tracking, flow cytometry, in vitro neutrophil assays\",\n      \"journal\": \"Acta biochimica et biophysica Sinica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse with defined phenotype, p38 MAPK pathway confirmed by inhibitor and RNA-seq, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"41517951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"TAFA4 acts as a neuron-derived mediator in intervertebral disc degeneration (IVDD). GINIP+ sensory neurons secrete TAFA4 in degenerative discs. In vitro, GINIP+ neurons promoted macrophage M2 polarization and IL-10 production while suppressing TNF-α and IL-1β; these effects were reversed by TAFA4 knockdown. TAFA4 attenuated ROS-dependent NLRP3 inflammasome activation in macrophages.\",\n      \"method\": \"In vivo IVDD model with lentiviral TAFA4 knockdown, in vitro neuron-macrophage co-culture, flow cytometry, immunofluorescence, ELISA, western blot\",\n      \"journal\": \"Neurospine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — defined pathway (TAFA4→macrophage M2/IL-10→NLRP3 suppression) with multiple in vitro and in vivo methods, single lab\",\n      \"pmids\": [\"41666872\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"During herpes simplex virus type 1 infection, sensory neurons produce TAFA4. In infected dorsal root ganglia (DRGs), a TAFA4-IL-10 pathway promotes the resolution of inflammation after viral clearance, functioning independently from substance P actions in skin. This neuroimmune regulatory pathway reduces detrimental impact of infection on host fitness without directly altering pathogen elimination.\",\n      \"method\": \"HSV-1 mouse infection model, tissue-specific analysis of DRG vs. skin, genetic and pharmacological dissection of SP and TAFA4 pathways\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — defined TAFA4-IL-10 axis in DRG with in vivo viral infection model, tissue-specific pathway established, single lab\",\n      \"pmids\": [\"41747735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In a Shank3 mouse model of autism, C-fiber low-threshold mechanoreceptors (C-LTMRs) are hyporesponsive and TAFA4 is transcriptomically downregulated. TAFA4 injection reduced spontaneous scratching response to skin deformation but failed to restore itch sensitivity, suggesting TAFA4 modulates one component of mechanical itch but not the full alloknesis pathway.\",\n      \"method\": \"Ex vivo electrophysiology of C-LTMRs, transcriptomic analysis, TAFA4 pharmacological injection, Shank3 ΔC/ΔC mouse model\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — preprint, partial mechanistic follow-up, negative result for itch restoration, single lab\",\n      \"pmids\": [\"bio_10.1101_2024.12.29.630575\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"TAFA4 is a secreted neuropeptide/neurokine produced primarily by C-low-threshold mechanoreceptors (C-LTMRs) that acts as a ligand for formyl peptide receptor 1 (FPR1) and lipoprotein receptor-related proteins (LRPs) to exert analgesic effects by modulating spinal cord interneuron excitability (via A-type K+ currents) and to drive anti-inflammatory, pro-repair macrophage responses (via TAFA4-IL-10 axis and LRP1-dependent M2 polarization), while also signaling through FPR1-MyD88-AKT in dendritic cells and through a PTEN-PU.1 axis in mast cells to suppress allergic responses, and promoting neutrophil ROS production through p38 MAPK during sepsis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TAFA4 (FAM19A4) is a secreted neurokine produced by C-low-threshold mechanoreceptors (C-LTMRs), a subset of GINIP+ sensory neurons, that links somatosensory neurons to neuronal excitability control and innate immune regulation [#0, #2]. As a marker of C-LTMRs, neuron-derived TAFA4 exerts an analgesic role: TAFA4-null mice show enhanced mechanical and chemical hypersensitivity with hyperexcitable spinal lamina II interneurons, and recombinant TAFA4 reverses this excitability and carrageenan-induced hypersensitivity [#0]. This antihypersensitive action operates through low-density lipoprotein receptor-related proteins (LRPs), with TAFA4 normalizing injury-induced changes in A-type K+ current and Ih in spinal interneurons in an LRP-dependent manner [#3]. Independently, TAFA4 functions as a ligand for formyl peptide receptor 1 (FPR1), driving macrophage chemotaxis, phagocytosis, Akt phosphorylation, and ROS release [#1]. Across tissues TAFA4 reprograms innate immune cells toward anti-inflammatory, pro-repair states, promoting macrophage M2 polarization and IL-10 production—via an LRP1-dependent route in dorsal root ganglia—to limit fibrosis, neuropathic pain, NLRP3 inflammasome activation, and post-infection inflammation [#2, #6, #8, #9]. In adaptive and allergic immunity, TAFA4 signals through FPR1-MyD88-AKT in dendritic cells to induce Tr1 cells and through a PTEN-PU.1 axis in mast cells to restrict FcεRI expression, attenuating allergic rhinitis [#4, #5]. In contrast, during sepsis TAFA4 enhances neutrophil ROS and NET formation through p38 MAPK, where its deficiency improves survival [#7].\",\n  \"teleology\": [\n    {\n      \"year\": 2013,\n      \"claim\": \"Established that a C-LTMR-specific secreted factor controls somatosensory thresholds, defining TAFA4 as an endogenous analgesic neuromodulator rather than a passive neuronal marker.\",\n      \"evidence\": \"Genetic labeling, TAFA4-null mice, spinal electrophysiology, and rescue by intrathecal/bath recombinant TAFA4 across multiple pain models\",\n      \"pmids\": [\"24139797\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor mediating the neuronal excitability effect not identified in this study\", \"Molecular target of the excitability change (ion channel) not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified a receptor for TAFA4, showing it acts as an FPR1 ligand to control macrophage chemotaxis and effector functions, opening an immune dimension to a neuronal factor.\",\n      \"evidence\": \"Radioligand binding, receptor internalization and blockade assays, in vitro chemotaxis, in vivo phagocytosis, and Akt phosphorylation western blot\",\n      \"pmids\": [\"25109685\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FPR1 mediates the in vivo analgesic effect not tested\", \"No structural basis for TAFA4-FPR1 binding\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Connected neuron-derived TAFA4 to tissue repair via a defined TAFA4-IL-10 macrophage axis, establishing a neuroimmune circuit controlling dermal macrophage survival and inflammatory tone.\",\n      \"evidence\": \"Conditional sensory neuron ablation, Tafa4-deficient mice, UV-skin damage model, in vitro macrophage stimulation, flow cytometry, histology\",\n      \"pmids\": [\"34012116\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor on dermal macrophages not defined in this study\", \"Direct vs indirect induction of IL-10 not fully separated\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Resolved the receptor requirement for TAFA4's analgesic action, showing LRPs mediate normalization of specific spinal interneuron ion currents.\",\n      \"evidence\": \"Multiple pain models, RAP pharmacological blockade, and electrophysiological recording of A-type K+ current and Ih in spinal interneurons\",\n      \"pmids\": [\"34706225\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific LRP family member not pinpointed\", \"Downstream signaling from LRP to ion channels unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Extended TAFA4 signaling to dendritic cells, defining an FPR1-MyD88-AKT pathway that drives regulatory T cell induction and dampens allergic responses.\",\n      \"evidence\": \"Mouse allergic rhinitis model, in vitro DC stimulation, pathway inhibitor assays, flow cytometry for Tr1 cells\",\n      \"pmids\": [\"36316414\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Pathway assigned by inhibitors without mutagenesis\", \"Single lab\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified a distinct mast-cell mechanism, the TAFA4-PTEN-PU.1 axis restricting Fcer1g transcription, broadening TAFA4's suppression of allergic activation.\",\n      \"evidence\": \"Patient nasal secretion ELISA, mouse allergic rhinitis model, in vitro mast cell stimulation, Fcer1g transcriptional analysis\",\n      \"pmids\": [\"36368013\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct binding or receptor identified for the mast cell effect\", \"Mechanistic link from receptor to PTEN unestablished\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Demonstrated that boosting TAFA4 alleviates neuropathic pain via LRP1-dependent macrophage M2 polarization, unifying analgesic and immunomodulatory functions in a gain-of-function setting.\",\n      \"evidence\": \"CCI rat model with scAAV-mediated TAFA4 overexpression, flow cytometry, western blot, immunofluorescence, ELISA\",\n      \"pmids\": [\"40381955\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic detail limited\", \"Relationship between LRP1 macrophage signaling and the earlier neuronal LRP effect not reconciled\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Showed a context-dependent pro-inflammatory role in sepsis, where TAFA4 enhances neutrophil ROS and NET formation via p38 MAPK and its loss is protective, revealing the factor is not uniformly anti-inflammatory.\",\n      \"evidence\": \"Fam19a4 knockout CLP sepsis model, bulk RNA-seq, p38 inhibitor SB203580, ROS bioluminescence tracking, in vitro neutrophil assays\",\n      \"pmids\": [\"41517951\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor mediating neutrophil effect not identified\", \"Source of TAFA4 in sepsis not defined\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Generalized the TAFA4-IL-10 anti-inflammatory axis to disc degeneration and viral infection, establishing TAFA4 as a neuron-to-macrophage signal resolving inflammation across diverse pathologies.\",\n      \"evidence\": \"IVDD model with lentiviral TAFA4 knockdown and neuron-macrophage co-culture; HSV-1 DRG infection model with genetic/pharmacological dissection of TAFA4 vs substance P\",\n      \"pmids\": [\"41666872\", \"41747735\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor mediating M2/IL-10 induction not resolved in these systems\", \"NLRP3 suppression mechanism beyond ROS not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How a single secreted factor selects among distinct receptors (FPR1 vs LRP/LRP1) and opposing immune outcomes (anti-inflammatory IL-10/M2 vs pro-inflammatory neutrophil ROS) in a cell- and context-specific manner remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural or biochemical basis distinguishing FPR1 vs LRP engagement\", \"Determinants of pro- vs anti-inflammatory switching unknown\", \"Receptor mediating spinal neuronal excitability changes not molecularly defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 3, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 1, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [1, 2, 4, 5, 7]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 4, 6]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"FPR1\", \"LRP1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}